Our review article entitled "Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023" was accepted for publication in the International Journal of Pharmaceutics: X. This review analyzed the amorphous solid dispersion products approved by the U.S. Food and Drug Administration in the 12-year period between 2012 and 2023, detailing several aspects and trends of DPI and DP formulation and manufacturing, as well as aspects of therapeutic category, dose, and patient-centricity.